• We bring innovation to market
  • Our advice makes medical innovation a commercial success
  • We are your one-stop-partner, from market entry to market maturity

Focus

HealthEcon is one of the most experienced healthcare consulting companies in Europe. We are based in Basel, Switzerland. We have completed more than 1100 projects, since our establishment in 1981. We mainly provide consultation services on pharmaceuticals for the leading European markets, including

  • reimbursement and pricing analyses,
  • market access advice,
  • appraisal of clinical evidence and study design support.
  • AMNOG dossiers

HealthEcon - Swiss healthcare consulting since 1981

Services

Our competencies are best reflected by the range of services we provide.

Services are provided from our Basel office.
If required, HealthEcon staff also temporarily works on-site with clients’ project teams at their regional offices.

Value Centric Medical Data Generation

  • Determination of unmet medical need and selection of target patient population
  • Shaping clinical trial designs
  • Framing a continuous data generation throughout the life cycle of a medical product
  • Formal quality assessments of clinical trials (e.g. CONSORT, GRADE, EVITA)

Value Centric Regulatory Strategy

  • Aligning regulatory strategy with payer strategy
  • Shaping optimal indication statement
  • Selection of meaningful endpoints, Including patient reported endpoints
  • Metaanalyses
  • Literatur analyses

Medical Writing and Publication Support

  • Setting up key messages for medical and payer stakeholders
  • Developing a publication strategy
  • Leveraging publication strategy to penetrate value messages
  • Developing respective congress presentations and full length publications

Scientific Expert Interaction

  • Setting up medical and payer advisory boards
  • Supporting & Conducting Stakeholder Advisory meetings (Regulatory & Payer Stakeholders: EMA/ NICE/ GBA etc.)

Payer Research & Pricing Analysis

  • Conducting payer research incl payer face to face interviews
  • Development of strategic pricing frameworks

International Payer Strategy Plans

  • Supporting the development of international Access Plans
  • Designing value centric presentation of clinical data set
  • Outlining life cycle pricing strategy
  • Developing EUNetHTA core models

HTA for pharmaceuticals

  • Preparation of AMNOG Dossiers
  • Preparing oral stakeholder hearings
  • Setting up early advice meetings

Supporting Price Negotiations

  • Development of targeted pricing strategy
  • Designing BATNA options (Best Alternative To No Agreement)
  • Outlining arbitration board strategies

Projects

Since our establishment in 1981, we have completed more than 1100 projects for over 200 clients. We have supported European governments, associations, sickness funds and pharmaceutical companies. Our clients include most of the global top 20 pharmaceutical companies, as well as small and medium-sized biotech companies.

Reference are available upon request.

Management

Prof. Dr. Jörg Ruof

Prof. Dr. Jörg Ruof

Chief Executive Officer

Dr. Stephan Ruckdäschel

Dr. Stephan Ruckdäschel

Managing Director

Publications

  • BMC Health Services Research

    BMC Health Services Research

    Staab et al (2016)

    Inconsistent approaches of the G-BA regarding acceptance of primary study endpoints as being relevant to patients - an analysis of three disease areas: oncological, metabolic, and infectious diseases

  • Health Economics Review

    Health Economics Review

    Ruof et al (2016)

    Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany – are additional data requirements by the Federal Joint Committee justified?

  • Value in Health

    Value in Health

    Ruof et al (2014)

    Questioning Patient Subgroups for Benefit Assessment: Challenging the German Gemeinsamer Bundesausschuss Approach

  • European Journal of Health Economics

    European Journal of Health Economics

    Ruof et al (2014)

    Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation

  • Posterpräsentation 9. Jahrestagung Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)

    Posterpräsentation 9. Jahrestagung Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)

    Rottenkolber at al (2017)

    Sozialmedizinische Aspekte von Brustkrebs –ein Literaturreview mit Fokus auf Deutschland

IGES Group

Since 2012, HealthEcon has been part of the IGES Group—an independent provider of research and consultancy services for the life sciences industry. It covers the entire range of services from market data, regulatory and health technology assessments to analysis of clinical services
As part of the IGES Group, we have been able to expand our capabilities and capacities, particularly in the fields of health services research, clinical research and real-life databases HealthEcon works as an independent entity on the market.

The IGES Institute is the core of the IGES Group. It offers comprehensive services based on expertise: studies, reports, publications, evaluations, concepts and strategies. Since its foundation in 1980, it has conducted over 2,000 research and consulting projects. The IGES Institute is based in Berlin, with additional offices in Nürnberg and Hamburg.

CSG (Clinical Study Group) is an independent contract research organization, supporting clients in planning, implementing and analyzing clinical-scientific studies. CSG is based in Berlin.

IMC clinicon is a consulting and services institute for hospital benchmarking, performance data, process optimization and quality management. IMC clinicon is based in Berlin.

AiM (Assessment in Medicine) is a health-economic consulting agency for the medical device industry, dedicated to reimbursement programs. Health technology assessment dossiers are founded on qualitative and scientific methodologies. AiM is based in Lörrach (Black Forest).

HealthEcon® AG
Steinentorstrasse 19
4051 Basel
Switzerland

+41 (0)61-284 95 60

info@healthecon.com

www.healthecon.com